Dr Roxburgh has 20 years experience in the AOD research sector. She has expertise in drug use and related harms (particularly mortality) in Australia. Her current program of work investigates fatal and non-fatal overdose in the context of changing drug markets.

Paul Dietze is one of Australia's leading alcohol and other drug researchers.

Shelley’s academic background is in the social and health sciences, with postgraduate qualifications in public health. She has 25 years’ experience working in the harm reduction sector with people who inject drugs. Shelley currently works at Melbourne’s Medically Supervised Injecting Room at North Richmond Community Health.

Shelley has a background in nursing, youth work and community development. She is a Research Fellow at the Burnet Institute and her work is focused on the lived experiences of people who use and inject drugs, criminal justice issues, infectious diseases and international development.

Professor Lisa Maher is Program Head at the Kirby Institute, Professor in the Faculty of Medicine at UNSW Sydney, NHMRC Senior Research Fellow, and a Burnet Institute Honorary Senior Principal Research Fellow. She has more two decades of international experience in research, program development and service delivery with vulnerable populations.